Avita Medical (RCEL) announced that the board of directors has named Chairman of the Board Cary Vance as Interim Chief Executive Officer, effective immediately. In conjunction with this appointment, Jim Corbett is leaving his positions as CEO and member of the Board. Vance will continue to serve as Chairman of the Board, while board member Jan Stern Reed has been appointed Lead Independent Director. The board intends to engage an executive search firm to assist with selecting a permanent CEO. This process will include a mix of internal and external candidates, including Vance, the company stated.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RCEL:
- Avita Medical downgraded to Hold from Buy at Lake Street
- Avita Medical Appoints Cary Vance as Interim CEO
- Avita Medical to be eligible for NTAP reimbursement from CMS for RECELL
- Avita Medical says data shows hospital stay reduction with RCELL System
- Avita Medical Announces $15M Equity Placement Agreement